Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | PFR; EN6200 | IM / RA |
2nd vaccination of COVID series given 3/12/21 (first given 2/19/21), and patient come to emergency department on 5/24/21 with "two days of light headedness, chest pain, shortness of breath, and palpitations" however states that has had this previously. This has since resolved and underwent a cardiac work-up with preexisting cardiac stents, ruled out acute cardiac event though noted with new palpitations that was medically managed.
VACCINATION COVID-19 PFIZER GIVEN 2/19/2021 AND 3/12/2021; SYMPTOMS MOST ACUTE AFTER THE SECOND VACCINATION WITH PALPITATIONS, SWEATS/CHILLS, NOT FEELING WELL, AND NOW CONTINUED FATIGUE.
HYPOTHYROIDISM, AORTIC ANEURYSM S/P REPAIR, S/P CARDIAC STENTS, HTN, OBSTRUCTIVE SLEEP APNEA ON SLEEP SUPPORT WITH AUTOPAP
NOT KNOWN
ATORVASTATIN (MUSCLE PAIN), TICLOPIDINE (RASH)
Inpatient hospital stay for 2 days with diagnosis of atypical chest pain with recommendation for heart monitoring at discharge and given myocardial perfusion stress test.